This topic contains a solution. Click here to go to the answer

Author Question: In which renal disease do substances from the immune response to streptococcus bacteria collect in ... (Read 64 times)

WhattoUnderstand

  • Hero Member
  • *****
  • Posts: 517
In which renal disease do substances from the immune response to streptococcus bacteria collect in the capillary network of the nephron?
 
  A) nephrotic syndrome
  B) pyelonephritis
  C) glomerulonephritis
  D) acute renal failure

Question 2

Write the correct meaning for PT:
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vish98

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

C
Explanation: A) This does not describe nephrotic syndrome.
B) Pyelonephritis is an infection, not an immune response.
C) Correct Antigenantibody complexes from the immune response clog the glomeruli.
D) This does not describe acute renal failure.

Answer to Question 2

prothrombin time




WhattoUnderstand

  • Member
  • Posts: 517
Reply 2 on: Jun 27, 2018
Great answer, keep it coming :)


ttt030911

  • Member
  • Posts: 315
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

For a complete list of videos, visit our video library